Downregulation of circ‐RAPGEF5 inhibits colorectal cancer progression by reducing the expression of polypeptide N‐acetylgalactosaminyltransferase 3 (GALNT3)
Environmental Toxicology · 2024
DOI: 10.1002/tox.24278 ↗Kurz gefasst
Fachartikel in der Zeitschrift Environmental Toxicology, 2024. Verfasst von Duo Cheng und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology and Rehabilitation, Zhengzhou Central Hospital Affiliated to Zhengzhou University, Zhengzhou City, Henan, China. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Down-Regulation, N-Acetylgalactosaminyltransferases, RNA, Circular. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: Key scientific research projects of Higher Education of Henan, China, The Key Project of Medical Science and Technology in Henan Province, China.
Abstract (Originalsprache)
Background
Circular RNA (circRNA) plays a crucial role in the pathogenesis and progression of colorectal cancer (CRC). However, the current understanding of the emerging function and mechanism of circ‐RAPGEF5 in CRC remains poorly understood.
Methods
We first evaluated the expression level of circ‐RAPGEF5 in CRC tissues and cells by quantitative real‐time polymerase chain reaction (qRT‐PCR). Then, we analyzed cell proliferation (EdU and colony formation assay), migration (cell wound healing assay), invasion (transwell assay), and apoptosis (flow cytometry assay). To further elucidate the mechanism of circ‐RAPGEF5 in CRC, bioinformatics tools, Dual‐luciferase reporter assay, Ago2 RNA immunoprecipitation assay, and RNA pull‐down assay were employed. Moreover, we established a CRC transplantation tumor model to evaluate the effect of circ‐RAPGEF5 on tumor growth in vivo. Results circ‐RAPGEF5 was significantly upregulated in CRC tissues and CRC cells. Furthermore, the downregulation of circ‐RAPGEF5 restrained CRC cell proliferation, migration, and invasion, and promoted cell apoptosis in vitro. Mechanistically, circ‐RAPGEF5 accelerated the malignant behaviors of CRC cells by sponging miR‐545‐5p, which targeted polypeptide N‐acetylgalactosaminyltransferase 3 (GALNT3). In addition, we revealed that circ‐RAPGEF5 silence curbed tumor growth in vivo.
Conclusion
These findings revealed that circ‐RAPGEF5 played an oncogenic role through the miR‐545‐5p/GALNT3 axis in CRC progression, providing potential therapeutic targets for the treatment of CRC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oncology and Rehabilitation, Zhengzhou Central Hospital Affiliated to Zhengzhou University, Zhengzhou City, Henan, China.
- Department of Digestive Diseases, Zhengzhou Central Hospital Affiliated to Zhengzhou University of Zhengzhou, Zhengzhou City, Henan, China.
ORCID-Profile: Duo Cheng
Förderung
- Key scientific research projects of Higher Education of Henan, China
- The Key Project of Medical Science and Technology in Henan Province, China
Zitieren
APA
Cheng, D., Chu, F., Liang, F., Zhang, N., Wang, J., & Yue, W. (2024). Downregulation of circ‐RAPGEF5 inhibits colorectal cancer progression by reducing the expression of polypeptide N‐acetylgalactosaminyltransferase 3 (GALNT3). Environmental Toxicology. https://doi.org/10.1002/tox.24278
Vancouver
Cheng D, Chu F, Liang F, Zhang N, Wang J, Yue W. Downregulation of circ‐RAPGEF5 inhibits colorectal cancer progression by reducing the expression of polypeptide N‐acetylgalactosaminyltransferase 3 (GALNT3). Environmental Toxicology. 2024. doi:10.1002/tox.24278
BibTeX
@article{Cheng2024,
author = {Cheng, Duo and Chu, Feifei and Liang, Fang and Zhang, Nan and Wang, Jingjing and Yue, Wenli},
title = {Downregulation of circ‐RAPGEF5 inhibits colorectal cancer progression by reducing the expression of polypeptide N‐acetylgalactosaminyltransferase 3 (GALNT3)},
journal = {Environmental Toxicology},
year = {2024},
doi = {10.1002/tox.24278}
}
EUVIMED